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Mast cells (MCs) are constitutively present in most tissues and a distinct subset of MCs can also be induced
upon host responses to inflammation. The hematopoietic lineage development of tissue MCs is unique
compared to other myeloid-derived cells because it is early lineage progenitors, undetectable by histochem-
istry, that leave the bone marrow to enter the circulation. These immature lineage MCs immediately undergo
transendothelial recruitment into peripheral tissues wherein the appearance of secretory granules with
a particular protease phenotype is regulated by the peripheral tissue. In this Perspective, we discuss our
current understanding of how these unique immunocytes arise, traffic to various sites, and may or may
not mature into tissue-directed granulated phenotypes and query whether a granulated end stage is their
only intended role.Introduction
The hematopoietic lineage for mast cell (MC) development
differs from that of other myeloid-derived cells in that MCs leave
the bone marrow (BM) as progenitors rather that as circulating
end-stage cells. These MC progenitors in the periphery, generi-
cally termed MCps, are identified by their expression of the
high-affinity receptor for immunoglobulin E (IgE), FcεRI, and
the stem cell factor (SCF) receptor Kit and by their ability to
form granulated MC colonies in culture. MCps enter the blood
and exit into tissues by transendothelial migration at such a
pace that they are virtually undetectable in the blood. This tissue
allocation of MCps is either constitutive, providing a measurable
baseline number, or largely inflammation induced. MCp differen-
tiate into twomajor subclasses of mature tissueMCs: a constitu-
tive subclass composed of connective tissue distributed MCs
(CTMCs), often located around venules and nerve endings, and
a T cell-dependent subclass composed of mucosal MCs
(MMCs), interepithelial in gut and respiratory mucosa. For both
subsets, recent evidence suggests that the expression of their
secretory granule proteases is directed by the local tissue in
which the cells reside.
This scenario raises numerous unresolved questions. Why did
adaptive immunity add a second subclass of mature MCs,
namely the MMCs? What is the purpose of sustaining tissue
reservoirs of MCps? For the small intestine, we rationalize that
it is to give rapid rise to induced MMCs, whereas for the lung,
a major recruitment of additional MCps is required, of which
only a small fraction is converted to MMCs and none become
CTMCs. Is it possible that these non- or hypogranulated consti-
tutive and induced tissue MCps have independent function(s)
that have not been recognized because these cells are essen-
tially invisible by standard histochemical and immunochemical
detection? Is the mature MC really so enriched with a capacity
to release abundant preformed proteases, amines, and pro-
teoglycans, newly generated lipid mediators such as prosta-
noids and leukotrienes, and readily induced chemokines and
cytokines because of its critical tissue location at portals of entryfor pathogens? These areas are some of the conundrums that
have occupied our thinking, and because of which we and others
have focused on the lineage development of MCs, the tissue
distribution of their lineage forms undetected by conventional
histochemistry, the differential expression of the MC-specific
proteases with cell maturation in different tissues, and the
recognition of functions of these proteases by their targeted
disruption.
Lineage Development of Progenitors
The derivation of MCs along the myeloid pathway is supported
by studies of MC development in vitro in cultures from BM
and by characterization of early lineage cells harvested from
peripheral tissues and induced to granulate ex vivo with appro-
priate growth factors. Such lineage studies were preceded by
the discoveries of Kitamura and colleagues of MC-deficient
strains and the demonstration that the MC lineage was BM
derived (Kitamura and Go, 1979; Kitamura et al., 1978, 1977).
The MC-deficient strains had a mutation in either the gene
coding for the tyrosine kinase receptor Kit or the gene encod-
ing its ligand, SCF. Because of other effects of these muta-
tions, the strains were F1 crosses between C57BL/6 mice
bearing one mutation and WB/ReJ or WC/ReJ mice bearing
a second mutation, respectively. These investigators showed
adoptive MC engraftment of the receptor-deficient strain
(WBB6F1/J-KitW/KitW-v, abbreviated W/Wv) with wild-type
(WBB6)F1 BM and of lethally irradiated C57BL/6 mice with
BM from C57BL-beige mice, which have distinct granules
and therefore allow identification of donor-derived MCs. In
the irradiated C57BL/6 mice, donor-derived MCs appeared
in the skin, stomach, and caecum, although most of the MCs
in the skin and mesentery were still host derived (Kitamura
et al., 1977). In the reconstituted W/Wv mice, these same
tissues were infiltrated with MCs, although the numbers in
skin never reached those of the wild-type (WT) F1 strain even
105 days after the transfer as confirmed by others (Du et al.,
1996; Kitamura et al., 1978).Immunity 37, July 27, 2012 ª2012 Elsevier Inc. 25
Figure 1. Mast Cell Lineage Development
Mast cells (MCs) are derived from the hematopoi-
etic stem cell (HSC) along the myeloid pathway.
Intermediate steps include the common myeloid
progenitor (CMP), which gives rise to the gran-
ulocyte macrophage progenitor (GMP). In BALB/c
mice, both Kit+FcεRI+ MC progenitors (MCps) and
Kit-FcεRI+ basophils (Bas) are found in the bone
marrow (BM). In C57BL/6 mice, it appears that
either BM CMPs or GMPs can directly differentiate
into MCps and Bas but FceRI+ MCps are rare to
absent in the C57BL/6 BM, whereas a bifunctional
progenitor that gives rise to both Bas and MCps
(BMCPs) is found in the spleen. In both strains,
committed MCps enter the circulation for the
transient purpose of transendothelial migration into
tissues where they can reside for a time or mature
and granulate. The dotted arrow notes the rare
FceR1KIT+ MC lineage precursors derived from
C57BL/6 BM CMPs and discussed in the text.
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myeloid lineage as derived in sequence from the Kit+Sca1+
hematopoietic stem cell (HSC), a Kit+Sca1loFcgRIIlo FcgRIIIlo
common myeloid progenitor (CMP), and then a Kit+Sca1Fc-
gRII/IIIhi granulocyte monocyte progenitor (GMP) (Figure 1).
This lineage gives rise to all granulocytes, neutrophils, basophils,
and eosinophils, as well as to macrophages and MCs (Akashi
et al., 2000, 2005). However, Galli and colleagues (Chen et al.,
2005; Franco et al., 2010) identified a rare FcεRIKIT+b7-integ-
rin+Sca1 progenitor for the MC lineage derived from a
KIT+Sca1lo CMP that sorted with the megakaryocyte-erythroid
progenitors in C57BL/6 BM. At the same time, in a collaboration
with Akashi and colleagues focused on the MC lineage, an
absence of MCps expressing FcεRI and Kit in BM from C57BL/
6 mice was observed (Arinobu et al., 2005). Given that MCp
homing to the small intestine of C57BL/6 and BALB/c mice
was known to require b7 integrin expression (Gurish et al.,
2001), Kit and b7 integrin expression were used to seek lineage
progenitors in the C57BL/6 strain by sorting and culture for their
progeny. A distinct cell type was found in spleen expressing Kit,
FcgRII/III, and high amounts of b7 integrin, but little or no FcεRI.
When cultured with the mixture of cytokines capable of driving
the maturation of the various granulocyte and macrophage line-
ages, these Kit+FcεRIb7-integrinhi spleen cells differentiated
only into basophils or MCs. All progeny either expressed high
levels of FcεRI and no Kit and were basophils by histochemistry
or expressed FcεRI and Kit and were MCs by histochemistry.
Thus, this cell appeared to be an intermediate step between
GMPs and MCps. This progenitor cell was termed a bifunctional
basophil-MC lineage progenitor (BMCP). The ability of BMCPs
to differentiate into MCs was confirmed in vivo by isolating and
transferring these cells to W/Wv mice and showing the develop-
ment of splenicMC 8weeks later. The numbers of splenic BMCP
in C57BL/6 mice increased after a helminth infection (Arinobu
et al., 2005) or the systemic administration of interleukin (IL)-3
(Ohmori et al., 2009). Importantly, others had not found any
increase in the number of BM cells capable of differentiating
into MCp in culture when evaluated by limiting dilution and cyto-
kine expansion in vitro in either (C57BL/63DBA/2)F1 (Dillon and
MacDonald, 1986) or in C57BL/6 mice (Guy-Grand et al., 1984)
after helminth infection. Thus, in C57BL/6 mice the principal26 Immunity 37, July 27, 2012 ª2012 Elsevier Inc.response for the MC lineage to helminth infection may occur
from Kit+FceR progenitors in the spleen.
In ontogeny, MC precursors appear in the yolk sac as early as
day 9.5 of gestation, peak in numbers at day 11, and fall off at day
13 (Sonoda et al., 1983). To generate these findings, Sonoda
et al. used an in vivo limiting dilution assay in which various
numbers of isolated yolk sac cells from (WBB6)F1 or C57BL/6-
beige mice were injected into different sites of the skin of
MC-deficient W/Wv mice and the resulting MC colonies were
enumerated by histology 5 weeks later. The decline in MC
precursors in the yolk sac was accompanied by increasing
numbers of MC precursors in the fetal liver, which peaked at
day 15 of gestation as determined by the same adoptive in vivo
assay (Hayashi et al., 1985). Rodewald and colleagues used cell
sorting of a KithiThy1lo population to identify a MC precursor that
peaked in number in blood at gestation day 15.5 in C57BL/6
mice (Rodewald et al., 1996). These cells wereweakly granulated
as assessed by staining with toluidine blue; were FcεRI; ex-
pressed transcripts for the mouse MC-specific proteases
(mMCP)-2, mMCP-4, and CPA-3; responded with MC colony
formation in vitro to the combination of SCF and IL-3; and lacked
developmental potential in vitro for lymphocytes, granulocytes,
or macrophages. In C57BL/6 mice, day 15 of gestation is also
the time at which the embryonic skin is seeded with MCps,
again as assessed by the in vivo limiting dilution assay in which
isolated cells are injected into the skin of W/Wv mice (Hayashi
et al., 1985). The appearance of MCps in the embryonic skin is
followed at day 17 by the appearance of mature MC in skin sites.
It is not known whether the unique appearance in time and the
committed nature of these skin MCps, possibly from the yolk
sac or fetal liver, apply to other connective tissue sites.
The finding of early MC lineage precursors lacking expression
of FcεRI noted for fetal C57BL/6 mice seems to hold also for
MC precursors in BM of adult C57BL/6 and BALB/c mice.
Chen et al. (2005) found a Kit+FceRIb7-integrin+ST2+ cell in
C57BL/6 BM that gave rise only to MCs when cultured in vitro
and only reconstituted MCs in the peritoneal cavity, ear skin,
and stomach after transfer into MC-deficient mice. Lantz and
Huff (1995) found that granulation and FcεRI expression by
Kit+FcεRI BALB/c BM cells sorted by flow cytometry appeared
together when the cells were cultured with SCF and IL-3. Yuan
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cell population with SCF, IL-6, and IL-10 generated a
KithiThy1loFcεRI cell population that then preferentially re-
sponded to SCF and IL-3 in culture to give rise to poorly
granulated MCs. More directly, Jamur et al., using two mono-
clonal antibodies (mAb) developed against a transformed rat
line of leukocytes with metachromatic staining granules, demon-
strated that mAb BGD6 was highly selective for a rare BM
cell, whereas mAb AA4 recognized a FcεR1+ population (Jamur
et al., 2001, 2005). Affinity isolation with mAb BGD6 provided
a rare population of cells from BALB/c MC that were
Kit+FcεRICD34+CD13+AA4 and were committed to the MC
lineage. Culture of these cells required SCF and IL-3 and resulted
in a pure population of MCs. When these cells were injected
into a lethally irradiated syngeneic BALB/c recipient, granulated
MCs appeared in the spleen 12 days later. Although these MC
precursors, which represented only 0.02% of adult BALB/c BM
cells, were ungranulated and FceRI, by PCR they expressed
message for the a and b chains of FcεRI and for the MC-specific
proteases, mMCP-5 and CPA3.
A generalized scheme of MC development in C57BL/6 and
BALB/c mice beginning with FcεR1+ MCps is depicted in
Figure 1. However, commitment to the MC lineage occurs prior
to the appearance of FcεRI or the distinct metachromatic cyto-
plasmic granules that are the distinguishing characteristic of
mature MCs in each strain. Furthermore, it appears that the
BM of adult BALB/c mice has both a Kit+FcεRI committed
progenitor and a Kit+FcεRI+ MCp. Adult C57BL/6 mice lack the
BMKit+FcεRI+ MCp but have a Kit+FcεRI committed progenitor
and a bifunctional BMCP in their spleen that gives rise to MCs
both in vitro and in vivo. The BMCP population expands with
helminthic infection and the Kit+FcεRI BM progenitor may
respond transiently as well (Pennock and Grencis, 2004). Further
definition of these phenotypes and the lineage response to
inflammation may now be possible with cytofluorographic
approaches that distinguish the MC lineage from that of the
basophil and other cells of the myeloid pathway.
Tissue Entry and Distribution of Lineage Progenitors
In 1967, the presence of progenitors of the MC lineage was
identified in lymph nodes from highly immunized mice by culture
and by characterization of the cell progeny with ultrastructure
and histochemistry (Ginsburg and Lagunoff, 1967). Embryonic
fibroblast monolayers and antigen restimulation of the cultures
were required to uncover the expansion and maturation of
MC from progenitors. In retrospect, it is likely that fibroblasts
supplied SCF (Flanagan and Leder, 1990) and that antigen
restimulation supplied T cell-derived IL-3 to the mixed starting
population. More than a decade later, several laboratories
demonstrated that culture of mouse BM cells with IL-3-contain-
ing medium gave rise to MCs (Razin et al., 1981; Schrader, 1981)
or drove proliferation of MC clones (Nabel et al., 1981). Schrader
and others then used limiting dilution of tissue cell populations
and their culture with IL-3 to drive MC expansion in vitro and
thereby calculate the concentration of MCps in the harvested
cell populations of various tissues (Clark-Lewis et al., 1982;
Crapper and Schrader, 1983; Gurish et al., 2001; Guy-Grand
et al., 1984). Schrader and colleagues, in their analysis of CBA
strainmice, reported a concentration of3,000MCps permillionharvested cells in intestine, a log less in BM, and a further reduc-
tion in other peripheral tissues. Similar tissue relationships, ex-
pressed as MCps per million mononuclear cells (MNCs), occur
in naive BALB/c and C57BL/6 mice. Crapper and Schrader
(1983) also noted that immunization by injection of Keyhole
Limpet Hemocyanin with complete Freund’s adjuvant into the
footpads increased the number of MCps in the draining lymph
nodes but not in contralateral lymph nodes as early as 3 days
after antigen.
The observations that mouse MCs expressed transcripts for
b7, CD29 (b1), and CD49d (a4) integrins (Gurish et al., 1992a),
that the b7 integrins were linked to lymphocyte homing to the
gut (Bargatze et al., 1995), and that there was a large pool
of MCps in the small intestine (Crapper and Schrader, 1983;
Guy-Grand et al., 1984) led to a study of the role of the b7 integ-
rins in the establishment of this MCp reservoir. C57BL/6 mice
lacking b7 integrins were profoundly deficient in intestinal
MCps, assessed after isolation of the MNCs by density gradient
fractionation and assay by limiting dilution and clonal expansion
with SCF and IL-3 (Gurish et al., 2001). For defining the alpha
chain integrin partner for b7 in maintaining the integrity of the
intestinal pool of MCp, the pool in WT BALB/c mice was abol-
ished by sublethal irradiation and WT BM was administered
intravenously immediately thereafter. Reconstitution of the
intestinal pool of MCps occurred by 12 days, thereby allowing
intervention with blocking mAb to the various integrins and their
counterligands to assess for their role in reconstitution. Blocking
of b7, a4, or specifically a4b7 suppressed reconstitution,
whereas mAb directed to CD103 (aE) or CD29 (b1) integrins
had no effect. This finding placed the a4b7 integrin on the
MCp and indicated a critical role in homing in naive mice. Similar
blocking studies showed the counterligands for a4b7 integrin on
the intestinal microvasculature to be mucosal addressin cellular
adhesion molecule (MAdCAM)-1 and vascular cellular adhesion
molecule (VCAM)-1 (Abonia et al., 2005; Gurish et al., 2001). Of
particular note, after sublethal irradiation and BM reconstitution,
the recipient mice acquired MCps in the BM several days before
the MCps appeared in the small intestine, suggesting that the
donor WT BM needed residence in the recipient BM before
MCps could be delivered to the small intestine. This suggested
that normal constitutive homing of MCps to the small intestine
would be inhibited in naive WT mice simply by administering
blocking mAb to epitopes on the MCp. Indeed, every-other-
day administration to naive BALB/c mice of blocking mAb to
a4b7 but not to b1 integrins depleted the intestinal MCps over
1 week, implying a residence half-time of less than 7 days for
MCps in the small intestine (Abonia et al., 2005).
Because productive adhesion is associated with directed
migration, various chemokine receptor-deficient strains were
assessed for numbers of intestinal MCps per million MNCs.
Intestinal MCps were fewer in number in CXCR2-deficient
BALB/c mice but not in strains lacking CCR3 or CCR5 (Abonia
et al., 2005). Donor BM from a CXCR2-deficient strain failed to
reconstitute intestinal MCps in sublethally irradiated WT BALB/
c mice, revealing that the receptor function was on the MCp.
As then expected, the administration to naive WT BALB/c mice
of blocking Ab to CXCR2 every other day for 1 week profoundly
depleted the number of intestinal MCps. Homing of MCps to
the small intestine of naive WT mice is innate, given that miceImmunity 37, July 27, 2012 ª2012 Elsevier Inc. 27
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gene-deficient mice have normal numbers of intestinal MCps
per million MNCs assessed by limiting dilution (Gurish et al.,
2001; Guy-Grand et al., 1984). Homing is also intact in the intes-
tine of germ-free mice (Guy-Grand et al., 1984). It is reasonable
to suggest that the constitutive intestinal MCp reservoir provides
the bulk of the cells that mature to provide the MMC hyperplasia
associated with a T. spiralis infection in the small intestine and
clearance of the worm burden and that the lack of MCps
accounts for the impaired clearance in the b7 integrin-deficient
strain (Artis et al., 2000).
Because it was known that mature MMCs were induced in the
lung tissue of sensitized mice by repeated pulmonary antigen
challenge (Williams and Galli, 2000; Yu et al., 2006) yet resident
T cell-independent MCp were minimal in numbers, inflamma-
tion-based recruitment of lineage progenitors was assessed.
Sensitization of mice with ovalbumin adsorbed to alum adjuvant
followed by three aerosol challenges 17–19 days later resulted in
the appearance of MCps in lung tissue as assessed by dissoci-
ation to harvest MNCs and limiting dilution assay (Abonia et al.,
2006). The increments in MCp concentration in both BALB/c
and C57BL/6 mice a day after the last challenge were similar,
at 10-fold above the concentration in unchallenged mice
(Jones et al., 2009, 2010). The induced pulmonary recruitment
of MCps was absent in b7 integrin-deficient mice and was
blocked with the administration of anti-a4b7 or anti-a4b1integrin
during the antigen challenges, thus indicating adhesion-depen-
dent transendothelial migration by the MCps to enter the lung.
Because MAdCAM-1 is not present in lung, VCAM-1 was the
counterligand (Abonia et al., 2006; Hallgren et al., 2007).
Tissue entry of lineage MC progenitors is a T cell-independent
constitutive process for the small intestine of naive mice but can
be amplified by inflammation-dependent recruitment as mostly
shown for T cell-dependent Th2 cell processes in lung. However,
in the latter setting, a specific role for a classical Th2 cytokine in
MCp flux has not been established (Jones et al., 2009, 2010).
Subsequent granulation of tissue MCps, which results in
different protease phenotypes in intestine and lung of BALB/c
mice, is considered below. That little is known about the effi-
ciency of tissue-directed granulation of MCps highlights the
need to develop real-time assays of the MC lineage tissue
progenitors not directly detected by current techniques.
Tissue Maturation of Lineage Progenitors
In 1878, Paul Ehrlich discovered the classical MC, the CTMC, in
human tissues by staining with aniline dyes. He named the cell
Mastzellen because he thought the granules provided nourish-
ment (in the German language, ‘‘Mast’’ denotes food). Almost
a century later, Enerback showed CTMC to be one of two major
classes of MC in helminth-infected rats (Enerba¨ck, 1966a, b).
Whereas the CTMC could be fixed by all fixatives tested and
stained with either of the cationic dyes, alcian blue or safranin,
the MMC could be detected only with Carnoy’s or a weak
formaldehyde and acetic acid fixation and alcian blue staining.
These differences were attributed to an abundance of heparin
in the CTMC and its relative lack in the secretory granules of
the MMC. Formal proof some years later showed that CTMC
obtained from peritoneal cavity fluid of Sprague-Dawley rats
possessed a large proteoglycan with long glycosaminoglycan28 Immunity 37, July 27, 2012 ª2012 Elsevier Inc.adducts of heparin of >900,000 molecular weight (Robinson
et al., 1978; Yurt et al., 1977). In contrast, the MMC developed
in N. brasiliensis-infected rats had proteoglycans of 150,000
molecular weight with predominantly chondroitin sulfate A and
di-B and some E glycosaminoglycan chains (Stevens et al.,
1986).
Other differences between these two cell types in the rat
included their proteases and their production of eicosanoids
with activation. Rat CTMCs and MMCs differed in the amino
acid sequence of their major cationic secretory granule serine
proteases, chymase I for CTMCs, and chymase II for MMCs
(Le Trong et al., 1987; Woodbury et al., 1978). After activation,
peritoneal CTMC from Lewis rats infected with N. brasiliensis
generated only the prostanoid prostaglandin D2, whereas the
MMC harvested from the same rats generated both cysteinyl
leukotrienes and prostaglandin D2 and had a lower histamine
content (Heavey et al., 1988). These distinctions in mediator
profile for CTMCs and MMCs in the rat may reflect differences
in tissue-based regulation of these mediators rather than a fixed
subclass.
A critical distinction established in the mouse, rat, and human
is that CTMCs are constitutive and T cell independent while
MMCs are induced and T cell dependent as defined in the
intestine and mouse lung. Thus, adaptive immunity supplies
a particular MC subclass to portals of entry not covered by the
innate CTMC and such MMCs are lacking in mice and humans
without T cell function (Irani et al., 1987; Ruitenberg and
Elgersma, 1976). The finding that MC-deficient W/Wv mice re-
constitutedwith C57BL/6-beige BMdeveloped beige phenotype
MCs in skin and mesentery (CTMCs) and in the fore stomach
(MMCs) favors a single lineage progenitor for both subclasses
(Hatanaka et al., 1979; Kitamura et al., 1978, 1977). Furthermore,
the limited characterizations of MCps that constitutively home
to the intestine and of induced MCps that are recruited to lung
have not uncovered any differences. The induced intestinal
MMC in mice are transient and disappear from the epithelium
of the villi in 2 weeks as the intestinal worm burden is cleared
in an MMC-dependent manner (Friend et al., 1996). The intraepi-
thelial life span of MMC in trachea and large proximal airways
of sensitized and aerosol ovalbumin challenged mice is also
10–14 days after the last challenge (M.F.G. and K.F.A., unpub-
lished data). In contrast, the CTMC seem remarkably stable
(Fukuzumi et al., 1990; Kitamura et al., 1977).
In the mouse, the identification, cloning, and targeted disrup-
tion of MC-specific serine proteases and Cpa3 has allowed
development of a panel of antibodies suitable for defining the
protease profile of CTMCs and MMCs in the same organ such
as intestine and lung (Friend et al., 1998; Xing et al., 2011). The
MMCs in the intestine elicited with T. spiralis infection were
consistently positive only for the chymase, mMCP-1 whereas
the CTMCs lacked this protease and expressed mMCP-4
(a chymase), mMCP-5 (an elastase), mMCP-6 and -7 (tryptases),
and CPA3 (Friend et al., 1996, 1998). In contrast, in sensitized
mice undergoing seven aerosol antigen challenges to elicit
MMCs in their airways, both the tracheal CTMCs and the
induced intraepithelial MMCs were positive for these six prote-
ases by immunohistochemistry (Xing et al., 2011). In the large
airways of the lung, the CTMCs again expressed all six proteases
whereas the induced MMCs were positive for three of the group,
Figure 2. Distinct Mature Mast Cell Phenotypes in Different Tissues
Mast cells (MCs) localized in mucosal environments (MMCs) are induced whereas those localized in connective tissue environments (CTMCs) are constitutive.
MMCs are induced by Th2 cell inflammation such as in helminth infections in the intestine or allergic inflammation of the lung with little or no change in the CTMCs
of those tissues. In the small intestine, the CTMCs and MMCs show distinct patterns of expression of the MC-specific secretory granule proteases, mouse
MC protease (mMCP)-1, -4, -5, -6, and -7, and CPA3 that do not overlap. In contrast, in the trachea the protease expression patterns for CTMCs and MMCs
are the same and for large airways of the lung they overlap. Thus, the tissue seems to regulate the phenotype associated with end-stage granulation of CTMCs
and MMCs.
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protease profile for CTMCs as well as for MMCs, as revealed
by their protease phenotype differences in the trachea and large
airways from those of the small intestine. Furthermore, that
conversion to MMCs was reproducible only with the greater
numbers of MCps found with seven challenges implies a rela-
tively inefficient conversion for protease accumulation and
maturation of the MCps. Thus, it is reasonable to suspect that
there may be a possible additional function for the pool of tissue
MCps expressing FcεRI.
The fact that the phenotypic distinction between CTMCs and
MMCs is acquired during the local tissue development of these
subsets rather than fixed either by the genetic makeup of their
MCps or their classical location in connective tissue and epithe-
lium, respectively, is supported by in vitro studies. The histologic
and histochemical appearance of MCs derived in culture from
BM cells (BMMCs) and of MCs derived in culture from mesen-
teric lymph node cells (MLNCs) from helminth-infected mice
were considered to resemble that of MMCs (Crapper et al.,
1984; Guy-Grand et al., 1984; Rennick et al., 1995). These
BMMC- and MLNC-derived MCs stained with alcian blue and
not safranin, made chondroitin sulfate proteoglycans, expressed
minimal heparin, and stored only limited amounts of histamine
like MMC (Razin et al., 1983; Rennick et al., 1995; Serafin
et al., 1986). That BMMCs were not end-stage MMCs became
apparent by studies showing their further maturation with fibro-
blast coculture or with the addition of other cytokines. Coculture
of BMMCs with fibroblasts together with continued IL-3 expo-
sure increased synthesis of heparin proteoglycans and the
associated safranin staining, increased histamine content, and
shifted the activation-dependent eicosanoid profile toward
that of CTMCs (Dayton et al., 1988; Levi-Schaffer et al., 1986,
1987). Fibroblasts produce SCF (Flanagan and Leder, 1990)and soluble SCF in the presence of IL-3 increases the production
of heparin proteoglycans and induces stable transcripts for more
of the proteases in BMMC, but without the full maturation-related
granulation and safranin staining appearing in the fibroblast
cocultures (Gurish et al., 1992b).
BMMCs obtained with IL-3 alone expressed transcripts for
mMCP-5 and -6 and CPA3 and could be induced to express
the chymases mMCP-4 with the addition of SCF and mMCP-1
and -2 with the addition of IL-9 or IL-10 (Eklund et al., 1993;
Ghildyal et al., 1992a, b; McNeil et al., 1991). Nuclear run-on
analysis showed that all the chymases were expressed at the
level of transcription, but translation depended upon the stabili-
zation of the transcripts, as illustrated for the action of IL-10
(Xia et al., 1996). Rennick et al. (1995), using MLNC from
helminth-infected mice, demonstrated distinct and sequential
roles for IL-4 and IL-10 in conjunction with SCF in driving the
further development of these cells toward MCs. IL-4 was impli-
cated in an early expansion of immature progeny, after which
IL-10 further amplified granulation. Nonetheless, these cyto-
kine-developed MCs, even with the inclusion of SCF, had poorly
staining granules until cocultured with fibroblasts, again indi-
cating that these stromal cells were supplying more than just
SCF. Recently, at least one of these other potential fibroblast-
derived factors has been identified as IL-33, which stimulated
an increased expression of the tryptasemMCP-6 inWTBMMCs,
but not in IL-33 receptor-deficient (ST2 null) BMMCs (Kaieda
et al., 2010). Clearly, BMMCs and lymph node-derived cultured
MCs are not equivalent to MMCs but rather are highly pleiotropic
lineage intermediates with receptor-mediated responses and
a capacity to undergo further differentiation and maturation.
Taken together, the in vitro studies of MC lineage cells have
shown considerable ligand-receptor-directed flexibility in
development and expression of effector systems, but theseImmunity 37, July 27, 2012 ª2012 Elsevier Inc. 29
Immunity
Perspectiveapproaches have not achieved full histochemical maturation.
The latter appears to involve stromal cell interactions that, in vivo,
appear to be central to both granulation and tissue-related
differential protease expression.
Mast Cell-Specific Proteases as Lineage Markers
and Functional Components of Mature Cells
The MC-specific proteases have been used to characterize
lineage progenitors, to distinguish phenotypes among mature
cells, to provide strains null for studies of a single MC function,
and recently, to generate MC-deficient strains with intact Kit
function. In lineage development in BM, transcripts for MC-
specific proteases confirmed that the earliest committed lineage
progenitors expressed Kit but still lacked expression of FcεRI
(Arinobu et al., 2005; Jamur et al., 2005; Rodewald et al.,
1996). These protease markers were used again to identify the
more mature Kit+FcεRI+ MCps harvested from draining nodes
during helminth infection. Finally, the presence of the proteases
in mature cells revealed that the tissue regulated the phenotype
of mature CTMCs and MMCs.
The characterization of individual MC-specific mouse prote-
ases allowed identification of tissue-based differences in their
expression (Reynolds et al., 1990;Serafin et al., 1987, 1990)
and subsequently the generation of mice lacking a particular
protease but with normal MC numbers, tissue distribution, and
degranulation responses that could be used to seek specific
MC function (Shin et al., 2009; Younan et al., 2010; Lin et al.,
2011). Global MC functions had been addressed with the W/
Wv strain that also had Kit-dependent non-MC anomalies
associated with genetic loss of Kit functions. Pharmacologic
correction of the Kit-deficient strains by intravenous administra-
tion of BMMCs did not properly reconstitute tissue MC numbers
or distribution, perhaps because the phenotype of these cells
does not adequately mimic the developmental stage of the
endogenous MCps that seed various tissues. Alternatively or in
addition, critical factors for directed migration to and within
a tissue may only be present at a particular time of development.
Several laboratories have recently addressed this problem by
targeting MC-selective proteases to delete these cells. Dudeck
et al. (2011) used the mMCP-5 locus, with random insertion of
anmMCP-5-Cre construct into the genome to drive MC-specific
Cre expression, and then introduced the diphtheria toxin
receptor or diphtheria toxin A chain by crossing these mice to
mice with flanking lox (flox) sites around a stop codon within
these genes.When Feyerabend et al. (2011) used theCpa3 locus
to drive MC-specific Cre expression by homologous recombina-
tion of their Cpa3-Cre construct, MCs were unexpectedly
deleted by Cre-mediated toxicity. Also using the Cpa3 locus to
express Cre in transgenic mice, Lilla et al. (2011) crossed these
mice with mice having a floxed antiapoptotic protein, myeloid
cell leukemia-1. All of these novel mice on a C57BL/6 back-
ground also showed various degrees of deletion of the basophil
lineage, perhaps due to loss of the bifunctional BMCP critical for
the MC lineage. Whether or not all committed MC lineage
progenitors and inflammation-induced progeny are unavailable
needs to be documented for each strain by MC lineage assays
of tissues and their draining nodes in models of inflammation.
Studies with these strains already have supported the role
of MCs in systemic anaphylaxis, contact sensitivity, and30 Immunity 37, July 27, 2012 ª2012 Elsevier Inc.antigen-induced methacholine hypersensitivity in allergic lung
inflammation while questioning a role for MCs in allergic enceph-
alomyelitis and autoantibody-induced arthritis (Dudeck et al.,
2011; Feyerabend et al., 2011; Lilla et al., 2011; Sawaguchi
et al., 2012).
Investigations using mice with targeted depletion of the
different MC-specific proteases have identified roles for these
proteases in both host defense and inflammation. Mice lacking
the chymase mMCP-1 have decreased changes in intestinal
permeability and an associated delayed intestinal clearance of
adult T. spiralis (Knight et al., 2000; McDermott et al., 2003).
A strain lacking the chymase mMCP-4 is protected against
a bullous pemphigoid-like lesion elicited in neonateswith a rabbit
Ab directed to mouse type XVII collagen (Lin et al., 2011). This
strain also is protected against a scald burn, whereas topical
application of human MC chymase to the scald site in the first
postburn hour results in full injury with ulceration and down-
stream fibrosis (Younan et al., 2010). A strain deficient in
mMCP-5, an elastase, with secondary reductions in mMCP-4
and CPA3, also is protected in the scald burn model, and full
injury is restored with topical recombinant mMCP-5 or human
elastase but not with human MC chymase. A strain lacking
mMCP-6, a tryptase, was protected against an immune
complex-mediated arthritis after administration of an autoanti-
body to glucose-6 phosphate isomerase (Shin et al., 2009).
Protection was apparent in the reduced numbers of swollen
joints and in thickness of the ankle joints. The attendant reduc-
tion in synovial fluid neutrophils provided a cellular explanation
for this benefit given that mMCP-6 elicits their migration (Huang
et al., 1998). Also of interest was the protection of the articular
cartilage proteoglycan, aggrecan, in the null strain as compared
to its degradation with associated cartilage demineralization in
the WT mice. These findings appear inconsistent with the lack
of protection in the same model for the MC-deficient Cpa3-Cre
mouse (Feyerabend et al., 2011). The quantity of mAb to
glucose-6 phosphate isomerase showing no protection in the
MC-deficient Cpa3-Cre mouse may have been greater than the
dose used in showing protection against arthritis in the MC-
specific tryptase-deficient strain. There is no mandatory ‘‘proper
dose’’ for model initiation. Instead, the magnitude of the eliciting
signal or the time interval for assay after the insult may be based
on a ‘‘window’’ in which the participation of a specific cell or
a specific mediator can be inferred from amelioration in the
deficient strain. Even with that caveat, it is essential for the
deficiency to be singular and when possible subject to a specific
correction.
Concluding Remarks
Consideration of the lineage development, varied localization of
committed MCp, and differences in granulation of mature MC
suggests dual roles for these tissue progenitors. First, there
is the development of FcεRI+ histochemically undetected
hypogranular tissue MCps into either mature classical CTMCs
orMMCs, which differ in distribution within a tissue, T cell depen-
dence, and life span and are fully armed with the proteases
dictated by the organ of residence. This outcome is compatible
with a sentinel cell function that can be tested in single protease-
deficient strains by the loss of pathobiologic effects in a
controlled dose response for the insult. Second, there is the
Immunity
Perspectivepossibility that related lineage progenitors in peripheral tissues,
including spleen and draining nodes, are intended to be regula-
tory cells with amplifying or inhibiting functions. Perhaps the
classical contributions from exocytosis of preformed secretory
granule mediators are not needed or desired in this setting.
Such a role for these MCp remains to be proven. Our overall
view of functions at two different points of MC maturation is
consistent with the distinction of these cells from other myeloid
lineages that provide a particular circulating end-stage cells
that can be modulated in the tissues. For the MC lineage, it
may be that the hypogranular progenitors that leave the BM to
reside in certain peripheral tissues have function per se and
also or independently progress to granulated forms, both con-
stitutive and induced.
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